JF
XERS icon

Jump Financial’s Xeris Biopharma Holdings XERS Stock Holding History

Jump Financial’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-341,068
Closed -$2.68M – 2474
2025
Q4 		$2.68M Sell
341,068
-262,176
-43% -$2.06M 0.03% 571
2025
Q3 		$4.91M Sell
603,244
-153,159
-20% -$1.02M 0.06% 411
2025
Q2 		$3.53M Buy
756,403
+332,880
+79% +$1.53M 0.04% 531
2025
Q1 		$2.33M Buy
423,523
+394,739
+1,371% +$1.59M 0.03% 527
2024
Q4 		$97.6K Buy
+28,784
New +$92.6K ﹤0.01% 1544
2022
Q2 		– Sell
-23,100
Closed -$59K – 2069
2022
Q1 		$59K Buy
+23,100
New +$56.4K ﹤0.01% 1460

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jump Financial's XERS Position: Q1 2026 in Review

Jump Financial sold out of Xeris Biopharma Holdings (XERS) in Q1 2026, closing a stake of 341,068 shares — an estimated $2.68M sold.

Jump Financial first reported a position in XERS in Q1 2022 and held it in 6 quarters. The position peaked at $4.91M in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Jump Financial reported no remaining Xeris Biopharma Holdings position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 341,068 Xeris Biopharma Holdings shares in Q1 2026, an estimated $2.68M.
  • Jump Financial first reported a position in Xeris Biopharma Holdings in Q1 2022 and held it in 6 quarters.
  • Jump Financial's Xeris Biopharma Holdings position peaked at $4.91M in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.